Viewing Study NCT06153095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-05-17 @ 7:35 PM
Study NCT ID: NCT06153095
Status: WITHDRAWN
Last Update Posted: 2025-02-10
First Post: 2023-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Sponsor: Lyell Immunopharma, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
None Lupus Nephritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T-cell View
None CD19/20 View
None CD19 View
None CD20 View
None Lupus Nephritis View
None LN View
None Systemic Lupus Erythematosus View
None SLE View
None Active refractory systemic lupus erythematosus View
None Active refractory Lupus Nephritis View